Recordati reported EUR482.31M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Almirall EUR 517.4M 32K Dec/2025
GlaxoSmithKline GBP 5.34B 1.85B Mar/2026
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Orion EUR 302.9M 64.2M Mar/2026
Sanofi EUR 9.31B 1.2B Mar/2026